How do you incorporate ctDNA in the management of metastatic breast cancer?  

I do use ctDNA molecular profiling assays to detect actionable mutations or for trial matching fairly regularly in my metastatic patients. As for ctDNA tracking tests like Signatera, I would consider their use mainly when routine in-house tumor markers like CA15-3, 27-29, CEA do not correlate well w...